Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$4.03 +1.02 (+33.89%)
As of 04:00 PM Eastern

BNR vs. KDLY, EUDA, CORBF, ATPC, QIPT, BMGL, SERA, PIII, OPGN, and BDSX

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Kindly MD (KDLY), EUDA Health (EUDA), Global Cord Blood (CORBF), Agape ATP (ATPC), Quipt Home Medical (QIPT), Basel Medical Group (BMGL), Sera Prognostics (SERA), P3 Health Partners (PIII), OpGen (OPGN), and Biodesix (BDSX). These companies are all part of the "healthcare" industry.

Burning Rock Biotech vs. Its Competitors

Burning Rock Biotech (NASDAQ:BNR) and Kindly MD (NASDAQ:KDLY) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, community ranking, valuation, earnings and risk.

Kindly MD has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -83.50%. Kindly MD's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-83.50% -60.68% -42.30%
Kindly MD N/A N/A N/A

In the previous week, Burning Rock Biotech had 6 more articles in the media than Kindly MD. MarketBeat recorded 6 mentions for Burning Rock Biotech and 0 mentions for Kindly MD. Burning Rock Biotech's average media sentiment score of 0.11 beat Kindly MD's score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company Overall Sentiment
Burning Rock Biotech Neutral
Kindly MD Neutral

Burning Rock Biotech received 5 more outperform votes than Kindly MD when rated by MarketBeat users.

CompanyUnderperformOutperform
Burning Rock BiotechOutperform Votes
5
31.25%
Underperform Votes
11
68.75%
Kindly MDN/AN/A

30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 50.5% of Kindly MD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Kindly MD has lower revenue, but higher earnings than Burning Rock Biotech. Kindly MD is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$515.82M0.08-$92.07M-$1.89-2.13
Kindly MD$2.47M44.71-$4.64M-$0.77-23.82

Summary

Kindly MD beats Burning Rock Biotech on 7 of the 13 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ Exchange
Market Cap$43.37M$3.10B$14.25B$8.62B
Dividend YieldN/A31.25%2.60%4.18%
P/E Ratio-1.3414.2133.9919.96
Price / Sales0.08178.39321.96157.63
Price / CashN/A57.5630.9334.64
Price / Book0.384.755.444.69
Net Income-$92.07M-$22.21M$194.85M$248.14M
7 Day Performance37.07%5.14%2.16%2.39%
1 Month Performance63.82%6.90%3.28%6.05%
1 Year Performance-48.33%15.18%23.78%13.60%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
0.7294 of 5 stars
$4.03
+33.9%
N/A-61.4%$43.37M$515.82M-1.341,390News Coverage
Earnings Report
High Trading Volume
KDLY
Kindly MD
0.626 of 5 stars
$22.60
+0.8%
N/A+314.3%$136.10M$2.47M-29.35N/A
EUDA
EUDA Health
0.2537 of 5 stars
$3.66
+0.3%
N/A+47.4%$135.98M$4.01M0.002Gap Down
CORBF
Global Cord Blood
N/A$1.00
flat
N/A+1.6%$121.55M$196.12M0.001,200Gap Down
ATPC
Agape ATP
1.0455 of 5 stars
$1.59
-7.9%
N/A-67.0%$79.66M$1.29M-2.1840Positive News
QIPT
Quipt Home Medical
2.5315 of 5 stars
$1.73
-3.4%
$2.85
+64.7%
-35.0%$74.55M$240.85M-10.18800Options Volume
BMGL
Basel Medical Group
N/A$3.92
-35.5%
N/AN/A$72.34M$10.05M0.0036Positive News
Gap Down
High Trading Volume
SERA
Sera Prognostics
0.634 of 5 stars
$1.58
+1.3%
N/A-82.0%$59.52M$115K-1.60120News Coverage
High Trading Volume
PIII
P3 Health Partners
2.4197 of 5 stars
$7.03
-4.9%
$16.25
+131.2%
-79.3%$50.53M$1.49B-8.37500
OPGN
OpGen
N/A$4.54
-3.4%
N/A+93.8%$45.71M$2.67M0.00100Positive News
Short Interest ↓
Gap Down
BDSX
Biodesix
3.4879 of 5 stars
$0.31
+2.6%
$1.75
+464.9%
-79.4%$45.41M$74.46M-0.79220Short Interest ↑
Gap Down

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners